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Regulation of papillary plasma flow by angiotensin II. We examined in
anesthetized dogs the effects of left (L) intrarenal artery infusion of
angiotensin II (ALL) on renal hemodynamics, urinary concentration and
Na excretion, and papillary plasma flow (PPF) (measured by the
albumin accumulation technique) in both kidneys. Following All infu-
sion (0.5 ng/kg/min) into the L renal artery, urinary Na excretion
decreased and osmolality increased slightly ipsilaterally, whereas Na
excretion did not change significantly and osmolality decreased in the
right (R) kidney. PPF was significantly lower in the L compared to the
R kidney. When saline loading was superimposed on L intrarenal All
infusion, there was a blunted natriuretic response ipsilaterally with a
significantly smaller decrease in urine osmolality compared with the R
kidney. PPF increased significantly in the R, but not in the L kidney.
Finally, All blockade with saralasin prior to All infusion and saline
loading prevented the differences between the two kidneys, including
PPF. In all groups GFR and renal blood flow did not differ between the
two kidneys before or after All. These data suggest that All regulates
regional blood flow in the medulla, and that the exogenously adminis-
tered All induces papillary ischemia, which serves to preserve medul-
lary hypertonicity, preventing an increase in PPF during saline loading,
and possibly contributing to the diminished natriuretic response.
It is now widely recognized that angiotensin II (All) plays a
pivotal role in the regulation of renal hemodynamics, salt and
water balance, and arterial pressure [1]. Employing various
techniques, including micropuncture [21 and microperfusion of
isolated tubules [3] or arterioles [4], a number of studies have
clearly characterized the effects of All on the glomerular
microcirculation and fluid transport in the proximal tubule. In
contrast, the issue of whether All affects the medullary circu-
lation has been largely neglected.
In previous studies examining inner medullary hemodynam-
ics in various canine models of chronic sodium retention, we
have observed that activation of the renin-angiotensin system is
associated with markedly reduced papillary plasma flow (PPF)
[5—7], We further examined in normal dogs the effects on PPF of
furosemide, ethacrynic acid and chiorthiazide, since the loop
diuretics increase renal blood flow (RBF) but also stimulate
renal renin release, whereas chiorothiazide decreases RBF but
has no significant effect on renin release [8]. During euvolemic
diuresis furosemide and ethacrynic acid produced a marked
decrease in PPF despite a significant rise in RBF, whereas
chlorothiazide did not alter PPF despite a significant fall in
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RBF. Furthermore, the decrease in PPF produced by furose-
mide was prevented by saralasin, a specific All inhibitor,
without altering the other effects of this agent. In addition to
these functional relationships, morphological studies of the dog
kidney have demonstrated a medullary vascular architecture
compatible with regional regulation of medullary blood flow [9].
Thus, evidence appears compelling for a role of All in the
regulation of medullary blood flow. The present study was,
therefore, undertaken to examine the effects of intrarenal
infusion of All, at a dose not affecting glomerular filtration rate
(GFR) and RBF on PPF, urinary concentration and sodium
excretion during hydropenia, and after saline loading in normal
dogs.
Methods
Experiments were performed in mongrel dogs of either sex.
The animals were maintained on a daily diet containing 60 mEq
of sodium and 40 mEq of potassium and allowed free access to
water. Prior to the acute experiments the animals were placed
in metabolic cages for five days. After sodium balance was
achieved, the animals were anesthetized with sodum pento-
barbital (30 mg/kg i.v.) and surgery was performed. Through a
midline suprapubic incision both ureters were isolated 6 cm
below the renal pelvis, and a small longitudinal incision was
made in each ureter. Through the incision, each ureter was
catheterized with a 19-gauge polyethylene tube (Deseret Co.,
Sandy, Utah, USA) which was secured by sutures. The right
and left side of the rectum was then punctured with a 14-gauge
needle and a guide wire threaded through the needle on each
side and passed out of the anus. The distal end of each ureteral
catheter was passed into the guide wire and fastened by a
ligature. Aided by the guide wire, the ureteral catheters were
pulled through and their tips placed just outside the anus. This
arrangement allowed for shorter preparation time and accurate
collection of urine from each kidney during the acute experi-
ment. Finally, a loop was loosely placed around the right renal
artery and vein with a nonreacting Teflon suture impregnated
with braided polyester fiber (Tevdek 5, Deknatel Co., Queens
Village, New York, USA). The ends of the loop were exterior-
ized through a right flank puncture. After free flow of urine was
demonstrated from each ureteral catheter, the suprapubic inci-
sion was closed. During surgery the dogs received 500 ml of
0.9% saline to replace fluid losses and were allowed water ad
libitum after recovering from anesthesia.
On the following morning (approximately 20 hr after the
surgery) after blood was obtained for measurement of plasma
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renin activity (PRA), the dogs were anesthetized with pento-
barbital, an endotracheal tube was inserted and light anesthesia
was maintained throughout. Through a left flank incision the left
renal pedicle was gently dissected to fully expose the renal
artery. The right renal artery was also isolated by blunt tunnel-
ing through the retroperitoneal space posterior to the aorta. An
electromagnetic flow probe (model EP-408, Carolina Medical
Electronics, King, North Carolina, USA) was placed around
the left and right renal artery and total RBF was measured by
electromagnetic flow meters (model 501, Carolina Medical
Electronics). A 25-gauge curved needle was inserted into the
left renal artery distal to the flow probe and maintained patent
with 0.9% saline infused at 0.3 ml/min. After the flow probes
were in place, an umbilical tape was passed around the left renal
pedicle and a knot loosely tied. Both the Teflon loop and
umbilical tape were placed so that the renal artery and vein of
both kidneys could be simultaneously occluded at the time
when PPF was determined. Zero renal blood flow was deter-
mined by brief occlusion of each renal artery distal to the probe.
The flow probe was calibrated by in situ perfusion of the renal
artery at the conclusion of the experiment.
Initial blood and urine samples were obtained and a priming
dose of inulin was administered followed by a sustaining
infusion of inulin and 10% mannitol at 0.8 mI/mm to induce a
mild diuresis. After 60 minutes of equilibration time, two to
three 10-minute control clearance periods and control hemody-
namic measurements were obtained. Thereafter, four groups of
experiments were performed:
Group I. Control during hydropenia (N = 5)
In order to examine the effects of renal artery manipulation
on renal hemodynamics and PPF, and to compare the function
of the two kidneys, the infusion of 0.9% NaCl into the left renal
artery at the rate of 0.3 ml/min was continued following the
control measurements. After 20 minutes, two 10-minute (exper-
imental) clearance periods were obtained along with repeat
hemodynamic measurements.
Group II. Unilateral Al! infusion during hydropenia (N = 5)
The dogs were prepared as in group I except that after control
measurements were taken All was added to the intrarenal
artery infusion to deliver 0.5 nglkglmin. Mter 20 minutes, two
10-minute clearance periods were obtained along with repeat
hemodynamic measurements.
Group III. Saline loading superimposed on unilateral All
infusion (N = 6)
Ten minutes after starting the unilateral All infusion (0.5
ng/kg/min) into the left renal artery, acute saline loading was
achieved with 0.9% NaC1 infused at 2 ml/kg/min for 15 minutes,
followed by a constant infusion of 0.2 mI/kg/mm. After estab-
lishing a steady state, two 10-minute clearance periods and
hemodynamic measurements were obtained.
Group IV. All blockade with saralasin plus saline loading
superimposed on unilateral A!! infusion (N = 5)
After the initial 60 minute equilibration period, saralasin was
infused intravenously at 2 mg/kg/mm and continued throughout
the experiment. After a steady state was achieved (approxi-
mately 30 mm), the experiment proceeded as in Group III.
Immediately after the two experimental periods in each
group, PPF was determined in each kidney by the '251-albumin
accumulation technique as previously described [5]. PRA,
osmolality, inulin and sodium were determined as previously
described [5] and clearances calculated by standard methods.
All results are expressed as mean SE. The data were treated
statistically with one—way analysis of variance when compari-
sons were made among the four groups. Student's t-test for
paired comparisons was used to determine the statistical signif-
icance of a difference between two means in the same group of
animals. P < 0.05 was considered significant.
Results
Balance studies
The mean daily intake and urinary output of sodium for five
days before the acute experiment were averaged in each group
of dogs. The mean sodium intake and output were similar in the
four groups and were, respectively, 55 5 mEq/24 hr and 56
6 mEq/24 hr in group I, 55 4 mEq/24 hr and 56 3 mEq/24 hr
in group II, 63 3 mEq/24 hr and 63 3 mEq/24 hr in group III,
and 65 2 mEq/24 hr and 65 4 mEq/24 hr in group IV. PRA
was 5.3 0.9 in group I, 5.5 1.5 in group II, 4.5 1.2 in group
III, and 6.1 1.6 ng/ml/hr in group IV with no significant
difference among the four groups.
Clearance and hemodynamic experiments
Table 1 summarizes the results of the clearance and hemo-
dynamic measurements in group I. During the control period
urine volume, osmolality and sodium excretion were similar in
the two kidneys. During the experimental period urine volume
and sodium excretion did not change significantly in either
kidney; however, a similar slight, but significant, decrease in
urine osmolality was noted in both kidneys, reflecting the effect
of mannitol infusion. GFR and RBF were similar in the two
kidneys during the control period and remained stable during
the experimental period; in addition, similar PPF values were
observed in the two kidneys.
Table 2 summarizes the results of the clearance and hemo-
dynamic measurements in group II before and after intrarenal
infusion of All. During the control period urinary volume,
osmolality and sodium excretion were similar in the right and
the left kidney. After All infusion into the left kidney urine
volume did not change in either kidney; however, sodium
excretion decreased significantly ipsilaterally but did not change in
the right kidney. As a result of the mild mannitol—induced
diuresis, urinary osmolality decreased significantly in the right
kidney but was unchanged ipsilaterally. GFR and RBF were
similar in the right and left kidney before All infusion and
remained stable throughout the experiment as did the mean
arterial pressure (MAP).
Figure 1 depicts the changes in urinary osmolality and sodium
excretion in both kidneys in group II. Urine osmolality de-
creased 72 29 mOsm/kg/H20 in the right kidney, significantly
different from the change in the left kidney (increased 18 17
mOsm/kgIH2O). The decrement in sodium excretion in the left
kidney was 11.4 4.7 mEq/min, significantly greater than that
in the right kidney (4.0 3.1 mEq/min).
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Table 1. Function of the right and left kidney during hydropenia (Group l)
V Uosm UNaV FE Na C,,, RBF PPF
MAP HCT
R L
mi/mm
R L
mOsm/kg 1120
R L
Eq/min
R L
%
R
mi/mm
L R L
mI/mm mm Hg %
R L
mi/mm/bOg
C
B
P
0.6 0.7
0.6 0.7
±0.1
NS NS
768 859
706 799
<0.05 <0.05
29 27
32 28
NS NS
0.6
0.7
NS
0.4
0.5
NS
42
38
NS
40
37
NS
211 213
211 215
NS NS
123
123
NS
45
44
NS
23.8 23.V'
±3.2
a Values are mean 5EM; N = 5. Abbreviations are: R, right kidney; L, left kidney; V, urine volume; Uosm, urine osmolality; UNaV, absolute
sodium excretion; FE Na, fractional sodium excretion; C,,,, inulin clearance; RBF, renal blood flow; MAP, mean arterial pressure; Hct,
hematocrit; PPF, papillary plasma flow; C, control; E, experimental; P, probability value; NS, statistically not significant.
b Statistically not significant when compared with R
Table 2. Effects of intrarenal infusion of angiotensin II into the left kidney during hydropenia (Group 2)
V Uosm UN,,V FE Na C,,, RBF
MAP HCT
R L
mi/mm
R L
mOsm/kg 1120
R L
p.Eq/min
R L
%
R L
mi/mm
R L
mI/mm mm Hg %
C
E
P
0.5 0.6
0.1 0.1
0.5 0.5
0.1 0.1
NS NS
1027 953
277 159
955 971
263 143
<0.05 NS
31 24
19 10
27 14
16 6
NS <0.05
0.50
0.26
0.51
0.18
NS
0.36
0.10
0.23
0.10
<0.02
40 35
6 6
38 32
5 4
NS NS
231 247
18 17
230 241
17 17
NS NS
149
7
149
7
NS
38
1
38
I
NS
Values are mean SEM. N = 5. For abbreviations, see Table 1.
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Fig. 1. changes in urine osmolality ( Uosm) and sodium excretion (
UNaV) in the right (R) and left (L) kidney after intrarenal All infusion
into the L kidney under hydropenia, Bars indicate means SE.
Table 3 summarizes the clearance and hemodynamic mea-
Surements in group III before and after acute saline loading
superimposed on left intrarenal infusion of All. During the
control period, urinary volume, osmolality and sodium excre-
tion as well as GFR and RBF were similar in both kidneys.
After acute saline loading, urinary volume and sodium excre-
tion increased significantly in both kidneys; however, the
response in the left kidney was blunted. GFR and RBF did not
change after acute saline loading in either kidney. MAP re-
mained stable and hematocrit decreased significantly.
Figure 2 depicts the decrease in urinary osmolality and the
increase in sodium excretion in both kidneys in group III. The
R L
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0N
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U,
—400 0
P< 0.01
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Fig. 2. Changes in urine osmolality ( Uosm) and sodium excretion (
UNOV) in the right (R) and left (L) kidney during acute saline loading
superimposed on intra renal All infusion into the L kidney. Bars indicate
means SE.
decrement in urine osmolality in the right kidney was 247 50
mOsm/kg/H20, significantly greater than that in the left kidney
(133 49 mOsmlkg/H20). The increment in sodium excretion
in the right kidney was 65 20 p.Eq/min, significantly greater
than that in the left kidney (29 14 Eq/min).
Figure 3 illustrates the results of PPF measurements in both
kidneys during group II and group III experiments. After All
infusion during hydropenia PPF was 8.6 2.9 mllmin/100 g in
the left, significantly lower than 27.9 1.8 mllmin/l00 g in the
right kidney. Following All infusion and saline loading PPF was
still significantly lower in the left (17.4 2.6 mllmin/lOO g)
compared to the right kidney, 40.8 4.3 mllmin/l00 g. An
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Table 3. Effects of saline loading superimposed on intrarenal angiotensin II infusion into the left kidney (Group 3)
V Uosm UNaV FE Na C1,, RBF MAP HCT
R L R L R L R L R L R L
mi/mm mOsm/kg H20 p.Eq/min % mi/mm mi/mm mm Hg %
C 0.6 0.5 733 694 17 13 0.25 0.23 39 41 228 237 145 37
0.1 0.1 81 126 7 4 0.08 0.08 8 8 15 19 8 3
E 1.5 0.9 485 545 82 42 0.99 0.53 45 42 237 242 143 27
0.2 0.1 56 90 25 16 0.22 0.06 5 6 14 20 8 2
P <0.005 <0.05 <0,005 <0.025 <0.025 <0.05 < 0.005 < 0.01 NS NS NS NS NS <0.001
a Values are means SEM. N = 6. For abbreviations, see Table 1.
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Fig. 3. Papillary plasma flow (PPF) in the right (R) and left (L) kidney Fig. 4. Effects of intravenous saralasin administration on the saline
after All infusion into the left kidney during hydropenia and after saline loading induced changes in urine volume (V), urine osmolality (
loading. Uosm), sodium excretion ( UjV) and papillary plasma flow (PPF)
during unilateral All infusion into the left kidney. R, right kidney; L,
left kidney; NS, not significant.
Table 4. Effects of angiotensin II blockade with saralasin plus saline loading superimposed on unilateral angiotensin II infusiona
V Uosm UNaV FE Na C1,, RBF
MAP HCT
R L R L R L R L R L R L
ml/min mOsm/kg H20 p.Eq/mmn % ml/min mI/mm mm Hg %
C 0.5 0.6 860 835 3 4 0.13 0.06 38 36 238 236 124 42
0. 0.2 94 162 1 1 0.09 0.02 4 5 17 16 9 2
E 1.6 2.0 591 564 57 67 0.76 0.83 49 56 306 304 120 31
0.5 0.8 151 166 21 27 0.33 0.34 10 8 24 23 8 IP <0.05 <0.05 <0.05 <0.01 <0.05 < 0.05 < 0.05 <0.05 < 0.05 <0.025 <0.01 <0.025 NS < 0.005
a Values are mean SEM. N = 5. For abbreviations, see Table 1.
increase in PPF occurred after saline loading in both kidneys
but was statistically significant in the right kidney only.
Table 4 summarizes the clearance and hemodynamic mea-
surements in group IV. Urinary volume, osmolality and sodium
excretion were similar in the two kidneys during saralasin
infusion. After All infusion and superimposed acute saline
loading, urinary volume, sodium excretion, GFR and RBF
increased similarly and significantly in both kidneys. Urinary
osmolality decreased similarly and significantly in both kidneys.
MAP remained stable and hematocrit decreased significantly
with saline loading.
Figure 4 depicts the changes in urinary volume, osmolality,
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sodium excretion and PPF in both kidneys in group IV. The
increment in urinary volume and sodium excretion in the left
kidney was 1.4 0.7 mi/mm and 63 28 Eq/min, similar to
1.1 0.4 mllmin and 54 21 Eq mm in the right kidney,
respectively. The decrement in urinary osmolality in the left
kidney was 271 68, similar to 268 102 mOsm/kg/H20 in the
right kidney. During All blockade with saralasin, PPF in the left
kidney was 31.7 2.9 mlIminhlOO g, similar to 38.0 1.6
mI/minIlOO g in the right kidney following intrarenal All infu-
sion.
Discussion
The results of the present study demonstrate that intrarenal
infusion of All during hydropenia significantly decreases PPF
ipsilaterally without altering GFR or RBF. This reduction in
PPF is associated with preservation of urinary concentration
(despite a mild diuresis induced by mannitol) and decreased
sodium excretion compared to the contralateral control kidney.
In addition, when a saline load was superimposed, there was a
blunted diuretic and natnuretic response and less of a decrease
in urinary osmolality in the All infused kidney compared to the
control kidney. Moreover, PPF did not increase as in the
control kidney. These effects of All in the experimental kidney
were abolished by prior saralasin infusion, a specific All
inhibitor.
The dose of All used in the present study was similar to that
in the study of Johnson and Malvin [101. Although these
investigators found that the reduced urine volume and sodium
excretion after intrarenal All infusion was not associated with
changes in GFR, they observed a slight but significant decrease
in para-aminohippurate clearance and an increase in filtration
fraction. Similar results were reported by Fagard et a! [11] with
direct measurement of RBF by an electromagnetic flow probe.
The absence of a decrease in RBF in the present experiments
may be related to the greater stimulation of the renin—angi-
otensin system resulting from the extensive surgical preparation
required for the simultaneous bilateral determination of PPF. In
the present study baseline PRA was significantly higher than
that in either of the aforementioned studies [10, 11]. A de-
creased pressor response to All has been observed in chronic
sodium_depleted subjects and cirrhotics, situations in which the
renin—angiotensin system is stimulated [121. In chronic sodium
depletion the dose of All required to elicit a similar degree of
renal vasoconstriction is higher than when the system is less
activated. A significant correlation has been found between
PRA and the response of RBF to varying doses of All; the
higher the PRA, the smaller the decrease in RBF [131. This
diminished vascular sensitivity to All has been explained by a
greater portion of the vascular All receptors occupied when the
system is activated, leaving fewer receptor sites to be bound by
the exogenously administered All.
The finding of a marked decrease in PPF without a change in
RBF during All infusion in normal dogs is similar to our
previous finding in chronic caval dogs and salt_depleted dogs
with activation of the renin—angiotensin system [5, 61. Since
inner medullary blood flow constitutes only 1% of total RBF in
anesthetized dogs [141, changes in RBF may not be detected
even though a profound alteration in PPF occurs. However,
actual dissociation between total RBF and PPF has been
reported in a variety of circumstances. Fadem et al [151
reported that similar increases in total RBF induced by various
vasodilators in normal dogs were associated with disparate
responses in PPF. A marked increase in PPF was noted after
acetylcholine or bradykinin administration, whereas secretin
failed to alter PPF with a similar increase in total RBF.
Moreover, after the administration of furosemide or ethacrynic
acid in normal dogs, we have observed a low PPF in the
presence of a substantial increase in total RBF [8]. Taken
together, these data suggest independent regulation of the
cortical and inner medullary circulation.
Anatomical studies have revealed differences in the efferent
arterioles of the juxtamedullary glomeruli compared to their
superficial counterparts. The juxtamedullary efferent arterioles
are longer, larger in diameter, and contain more smooth muscle
cells [16]. They give way to the descending vasa recta, the
proximal portions of which are also enveloped by smooth
muscle cells, which are gradually replaced distally by pericytes
provided with contractile elements [6]. The possible functional
significance of this unique vascular architecture of the renal
medulla has recently been uncovered. Fried and Simpson [17]
have demonstrated messenger RNA coding for angiotensinogen
predominantly in the rat renal medulla. Ingelfinger et al [18]
have recently reported that angiotensinogen mRNA is ex-
pressed in apparently equal proportions in renal cortex and
medulla, and that the mRNA levels are augmented in response
to sodium deprivation. Using autoradiographic mapping, Men-
delsohn et al [19] demonstrated that All binding in the rat was
far more dense in the outer medulla than the cortex, and has
localized this binding to the vasa recta bundles in the outer
medulla [20]. Thus, the decrease in PPF induced by All in the
present study most likely reflects a direct effect on the medul-
lary vasculature, as has been recently postulated for arginine
vasopressin. Zimmerhackl, Robertson and Jamison [21], using
fluorescent videomicroscopy, have demonstrated that a physi-
ological dose of vasopressin reduced vasa recta blood flow in
rats without altering total RBF.
During both hydropenia and saline loading, intrarenal All
infusion was associated with relative preservation of urinary
concentration in the ipsilateral kidney (Figs. 2 and 3). In dog
models of salt retention with activation of the renin—angiotensin
system that we have previously studied, a lower PPF was
associated with higher urinary osmolality and papillary solute
content compared with normal dogs [5—7].This finding indicates
that solutes were added to the papillary interstitium at rates
exceeding their egress, which could be due to either enhanced
tubular transport or reduced removal, or both. Intrarenal All
infusion increases PGE2 production [22], thereby affecting
solute transport. PGE2, however, decreases NaC1 reabsorption
in the medullary thick ascending limb of Henle [23] and de-
creases urea reabsorption in the collecting duct [24], events
leading to a decrease in medullary solute content and urinary
concentration. On the other hand, All can stimulate norepi-
nephrine release from adrenergic nerve endings, and it is
possible that this effect may contribute to preservation of
urinary concentration by All as observed in the present exper-
iments. This possibility is supported by the observations that
addition of norepinephrine to the bathing media enhanced
chloride absorption in the isolated perfused, mouse medullary,
thick ascending limb [26], and that low—frequency renal nerve—
stimulation in the rat increases sodium chloride transport in the
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loop of Henle of superficial nephrons [25]. Finally, the en-
hanced urinary concentration may also be related to a direct
effect of All on solute transport in the cortical and medullary
thick ascending limb, since All receptors have been demon-
strated in these nephron segments [27].
It is now accepted that an increase in medullary blood flow
without a proportionate increase in tubular transport of solutes
into the medullary interstitium would result in solute washout
and loss of medullary tonicity [5]. A decrease in vasa recta
blood how would, therefore, be expected to enhance medullary
solute accumulation insofar as solute transport in the loop of
Henle and collecting duct does not decrease proportionately, as
formulated by the central core model of Stephenson [291 and the
dynamic model of Moore and Marsh [30]. Thus, the finding in
the present experiments are consistent with the notion that All
preserves urine concentration by decreasing PPF, particularly if
there is an associated increase in loop solute transport.
Intrarenal infusion of All significantly enhanced ipsilateral
sodium reabsorption (Table 2). A systemic release of aldoster-
one secondary to recirculation of the intrarenally infused All
cannot explain this finding since sodium reabsorption in the
contralateral kidney remained unchanged. It is possible that All
potentiated renal nerve norepinephrine release, thereby in-
creasing proximal, tubular sodium reabsorption [31]. However,
the antinatriuretic effect of All has been observed in acutely
denervated kidneys [32] as well as in isolated perfused, rabbit
proximal tubules [3]. Although experimental evidence for a
direct action of a low dose of All on sodium transport has been
limited to the proximal tubule [3], a similar action in a more
distal tubular segment cannot completely be ruled out, as noted
above.
Previous micropuncture and microcatheterization studies have
shown that during acute saline loading, sodium reabsorption in
the juxtamedullary nephron is inhibited more than in the
superficial nephron, with net addition of sodium between the
superficial late distal tubule and the papillary collecting duct
[33]. One explanation for this phenomenon is a decrease in
passive sodium transport in the thin ascending limb of Henle
due to the dissipation of the sodium gradient which normally
exists between this nephron segment and ascending vasa recta
[34]. The decreased osmotic gradient could result from medul-
lary solute washout secondary to augmented medullary blood
flow during acute saline loading in normal animals [5]. There is
also evidence for sodium addition to the tubular fluid in the
papillary collecting duct during acute saline loading [35]. Bal-
lerman and Brenner [36] have recently suggested that the
diuresis and natriuresis induced by atrial natriuretic peptide
(which is released during acute saline loading) result, in part,
from alterations in papillary hemodynamics. Specifically, after
infusion of the peptide in the rat, the hydraulic pressure in the
papillary vasa recta was markedly increased, preventing the
fluid absorbed from the papillary tubular structures from return-
ing to ascending vasa recta [37]. Thus, it is conceivable that the
papillary ischemia induced by All prevents the rise in the
hydraulic pressure in vasa recta after saline loading, thereby
leading to a blunted diuretic and natriuretic response.
In the present study, persistent papillary ischemia and a
blunted natriuresis accompanied by relative preservation of
urinary concentration were observed in the All-infused kidney
during saline loading, and were reversed by specific All block-
ade with saralasin. These actions of All mimic the findings in
dogs with chronic salt retention and activation of the renin—
angiotensin system; specifically, in dogs with chronic caval
constriction or an aortocaval fistula with avid salt retention, a
blunted natriuretic response to acute saline loading is associ-
ated with a markedly diminished PPF and conservation of
papiliary solute content when compared with normal dogs [5,
7]. Thus, the profound medullary ischemia produced by All
may be added to the several efferent mechanisms proposed for
chronic salt retention.
In summary, the present data suggest that All regulates
regional blood flow in the medulla and that the All-induced
papillary ischemia serves to preserve medullary hypertonicity
during hydropenia and saline loading and prevents an increase
in PPF during saline loading, possibly contributing to the
diminished natriuretic response.
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